Atlanta Biologicals, Inc.
Part of Bio-Techne Corporation
- UEI
- ULFTKRGFBBA5
- CAGE
- 3GC81
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
RDJKATCM39L5
-
Parent
RDJKATCM39L5
- SAM.gov registration date
- Website
- rndsystems.com
- Founded
- 1985
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Fetal bovine serum | National Cancer Institute (NIH) | $22,655 | |
| Atlanta biologicals INC:1109260 [18-051343] | National Cancer Institute (NIH) | $23,375 | |
| Fetal bovine serum purchase | CDC Pittsburgh | $17,343 | |
| Laboratory supplies | CDC Pittsburgh | $35,615 | |
| Fetal bovine serum (FBS), premium, heat inactivated | National Institute of Environmental Health Sciences (NIH) | $8,075 |
Latest 5 listed here. See the rest on GovTribe.
Quick answers
Is Atlanta Biologicals, Inc. registered in SAM.gov?
Atlanta Biologicals, Inc.'s SAM.gov registration expired on June 25, 2020.
What is Atlanta Biologicals, Inc.'s most recent federal award?
Atlanta Biologicals, Inc.'s most recent federal contract award is Fetal bovine serum (75N91019P00292), from National Cancer Institute (NIH), on April 16, 2019.
On GovTribe
See Atlanta Biologicals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors